Back

Myeloid-biased HSC require Semaphorin 4A from the bone marrow niche for self-renewal under stress and life-long persistence

Toghani, D.; Zeng, S.; Mahammadov, E.; Crosse, E. I.; Seyedhassantehrani, N.; Burns, C.; Gravano, D.; Radtke, S.; Kiem, H.-P.; Rodriguez, S.; Carlesso, N.; Pradeep, A.; Wilson, N. K.; Kinston, S. J.; Gottgens, B.; Nerlov, C.; Pietras, E.; Mesnieres, M.; Maes, C.; Kumanogoh, A.; Worzfeld, T.; Kharchenko, P.; Scialdone, A.; Spencer, J. A.; Silberstein, L.

2022-01-12 cell biology
10.1101/2022.01.12.476097 bioRxiv
Show abstract

Tissue stem cells are hierarchically organized. Those that are most primitive serve as key drivers of regenerative response but the signals that selectively preserve their functional integrity are largely unknown. Here, we identify a secreted factor, Semaphorin 4A (Sema4A), as a specific regulator of myeloid-biased hematopoietic stem cells (myHSC), which are positioned at the top of the HSC hierarchy. Lack of Sema4A leads to exaggerated myHSC (but not downstream "balanced" HSC) proliferation after acute inflammatory stress, indicating that Sema4A enforces myHSC quiescence. Strikingly, aged Sema4A knock-out myHSC expand but almost completely lose reconstitution capacity. The effect of Sema4A is non cell-autonomous, since upon transplantation into Sema4A-deficient environment, wild-type myHSC excessively proliferate but fail to engraft long-term. Sema4A constrains inflammatory signaling in myHSC and acts via a surface receptor Plexin-D1. Our data support a model whereby the most primitive tissue stem cells critically rely on a dedicated signal from the niche for self-renewal and life-long persistence.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cell Reports
○ 1498 papers in training set
Top 0.6%
14.8%
Similar papers in this journal
2
eLife
● 5828 papers in training set
Top 8%
11.7%
Similar papers in this journal
3
Cell Stem Cell
○ 62 papers in training set
Top 0.1%
9.5%
Similar papers in this journal
4
Cell Metabolism
○ 57 papers in training set
Top 0.2%
6.6%
Similar papers in this journal
5
Journal of Experimental Medicine
● 119 papers in training set
Top 0.3%
6.6%
Similar papers in this journal
6
Nature Communications
○ 5641 papers in training set
Top 27%
5.4%
50% of probability mass above
7
Cell
○ 431 papers in training set
Top 3%
3.4%
8
Molecular Cell
○ 350 papers in training set
Top 2%
3.4%
9
The EMBO Journal
○ 309 papers in training set
Top 1%
3.2%
10
Science Advances
● 1243 papers in training set
Top 11%
3.2%
11
Nature Cell Biology
○ 118 papers in training set
Top 1%
3.1%
12
Blood
● 74 papers in training set
Top 0.6%
2.7%
13
Developmental Cell
○ 196 papers in training set
Top 2%
2.3%
14
Immunity
○ 67 papers in training set
Top 0.8%
2.3%
15
Stem Cell Reports
○ 130 papers in training set
Top 0.9%
2.3%
16
EMBO Reports
○ 263 papers in training set
Top 3%
2.1%
17
Cell Research
○ 51 papers in training set
Top 0.6%
1.7%
18
iScience
○ 1154 papers in training set
Top 21%
1.5%
19
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 33%
1.3%
20
Life Science Alliance
● 285 papers in training set
Top 7%
1.0%
21
Development
● 497 papers in training set
Top 5%
0.6%
22
Science
● 477 papers in training set
Top 10%
0.6%
23
Science Translational Medicine
● 127 papers in training set
Top 4%
0.6%
24
Journal of Clinical Investigation
● 179 papers in training set
Top 7%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.